This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
moving-average-crossover: Archive
Newmont Corporation (NEM) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
NEMPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Mirum Pharmaceuticals (MIRM) Surges 7.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Mirum Pharmaceuticals (MIRM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
MIRMPositive Net Change OCSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Appian (APPN) Soars 6.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Appian (APPN) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
APPNPositive Net Change CRWDPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Bally's (BALY): Can Its 25.1% Jump Turn into More Strength?
by Zacks Equity Research
Bally's (BALY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BALYPositive Net Change HLTPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
XPeng Inc. Sponsored ADR (XPEV) Recently Broke Out Above the 50-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 50-Day simple moving average?
XPEVPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Jones Lang LaSalle (JLL) Surges 5.6%: Is This an Indication of Further Gains?
by Zacks Equity Research
Jones Lang LaSalle (JLL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
JLLPositive Net Change ZPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Strength Seen in Middleby (MIDD): Can Its 5.5% Jump Turn into More Strength?
by Zacks Equity Research
Middleby (MIDD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
MIDDPositive Net Change HLIOPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Beam Therapeutics (BEAM) Soars 7.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Beam Therapeutics (BEAM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BEAMPositive Net Change MRNAPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Citizens Community Bancorp (CZWI) Moves 5.1% Higher: Will This Strength Last?
by Zacks Equity Research
Citizens Community Bancorp (CZWI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
CZWIPositive Net Change FFICPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Transocean (RIG) Surges 10.7%: Is This an Indication of Further Gains?
by Zacks Equity Research
Transocean (RIG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
RIGPositive Net Change PDSPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
HanesBrands (HBI) Soars 5.8%: Is Further Upside Left in the Stock?
by Zacks Equity Research
HanesBrands (HBI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
HBIPositive Net Change RLPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Should You Buy BancFirst (BANF) After Golden Cross?
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
BANFPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Redwood Trust (RWT)'s Technical Outlook is Bright After Key Golden Cross
by Zacks Equity Research
Should investors be excited or worried when a stock's 50 -day simple moving average crosses above the 200-day simple moving average?
RWTPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Skillsoft (SKIL) Soars 18.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Skillsoft (SKIL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.
SKILPositive Net Change OBPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Brainsway (BWAY): Can Its 9.3% Jump Turn into More Strength?
by Zacks Equity Research
Brainsway (BWAY) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
BWAYPositive Net Change ICUIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Mistras (MG) Soars 5.4%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Mistras (MG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
MGPositive Net Change UEICPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Xeris Biopharma (XERS) Now Trades Above Golden Cross: Time to Buy?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
XERSPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Apple (AAPL) Recently Broke Out Above the 20-Day Moving Average
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?
AAPLPositive Net Change
daily-movers moving-average-crossover stocks-moving-today
Itron (ITRI) Crossed Above the 50-Day Moving Average: What That Means for Investors
by Zacks Equity Research
Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?
ITRIPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Inter Parfums (IPAR) Soars 8.9%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Inter Parfums (IPAR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
IPARPositive Net Change ELFPositive Net Change
momentum-stocks moving-average-crossover price-performance stock-price-movement stocks-moving-today
Owens & Minor (OMI) Stock Jumps 7.6%: Will It Continue to Soar?
by Zacks Equity Research
Owens & Minor (OMI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
OMIPositive Net Change AYRWFPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Golar LNG (GLNG) Moves 6.1% Higher: Will This Strength Last?
by Zacks Equity Research
Golar LNG (GLNG) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
GLNGPositive Net Change ZIMNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in Embecta Corp. (EMBC): Can Its 6.9% Jump Turn into More Strength?
by Zacks Equity Research
Embecta Corp. (EMBC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
EMBCPositive Net Change CORNegative Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Strength Seen in New York Times (NYT): Can Its 5.2% Jump Turn into More Strength?
by Zacks Equity Research
New York Times (NYT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
NYTPositive Net Change LEEPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today
Denali Therapeutics (DNLI) Stock Jumps 9.7%: Will It Continue to Soar?
by Zacks Equity Research
Denali Therapeutics (DNLI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.
DNLIPositive Net Change AMRNPositive Net Change
momentum-stocks moving-average-crossover stock-price-movement stocks-moving-today